Perrigo Reports Launch Of Store Brand OTC Equivalent To Mucinex 1200mgER Tablets

(RTTNews) - Perrigo Co. (PRGO) and its partner Allergan plc (AGN) announced the launch of guaifenesin 1200mg extended-release tablets, the OTC store brand equivalent to Mucinex 1200mg extended-release tablets to retail and wholesale customers.

First shipments of this new store branded product have been initiated and represents a first-to-market accomplishment for Perrigo and Allergan.

These products are packaged and marketed as store brands or retailer 'own label' brands and provide consumers a high-quality, value alternative to the Mucinex 1200mg extended-release product.

Mucinex 1200mg extended-release tablets (guaifenesin 1200mg extended-release tablets), indicated to relieve chest congestion and to break up mucus, making coughs more productive, produced sales of approximately $71 million through food, drug and mass merchants during that last twelve months.